EP2599767 - Phenylbutyl-derivatives [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.06.2014 Database last updated on 02.08.2024 | Most recent event Tooltip | 20.06.2014 | Application deemed to be withdrawn | published on 23.07.2014 [2014/30] | Applicant(s) | For all designated states Lunamed AG Rabengasse 4 7000 Chur / CH | [2013/23] | Inventor(s) | 01 /
Truog, Peter Rabengasse 4 7000 Chur / CH | 02 /
Buschmann, Helmut H. Sperberweg 15 52076 Aachen (Walheim) / DE | [2013/23] | Representative(s) | Peters, Hajo, et al ZACCO GmbH Bayerstrasse 83 80335 München / DE | [N/P] |
Former [2013/23] | Peters, Hajo, et al ZACCO GmbH Bayerstrasse 83 80335 München / DE | Application number, filing date | 11010059.1 | 21.12.2011 | [2013/23] | Priority number, date | EP20110009472 | 30.11.2011 Original published format: EP 11009472 | [2013/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2599767 | Date: | 05.06.2013 | Language: | EN | [2013/23] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 19.11.2012 | Classification | IPC: | C07C69/14, C07C69/612, C07C69/86, C07C229/36, C07C233/51, A61K31/216 | [2013/23] | CPC: |
C07C229/36 (EP);
C07C233/51 (EP);
C07C69/157 (EP);
C07C69/612 (EP);
C07C69/86 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/23] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | Phenylbutyl-Derivate | [2013/23] | English: | Phenylbutyl-derivatives | [2013/23] | French: | Dérivés de phénylbutyl | [2013/23] | Examination procedure | 06.12.2013 | Application deemed to be withdrawn, date of legal effect [2014/30] | 13.01.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2014/30] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.12.2013 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2010103976 (UNIV NAGOYA NAT UNIV CORP [JP], et al) [X] 1-7,10,13 * product of Scheme 3; page 16, paragraph 34 *; | [A]WO2008120205 (UNIV RAMOT [IL], et al) [A] 1-15 * claims 1, 8, 15, 53 * * page 2, lines 13-19 * * page 36; compounds AN-451 *; | [A]US5939455 (REPHAELI ADA [US]) [A] 1-15 * claims 1, 4, 5 * * column 1, lines 40-54 *; | [X] - WALSH JAMES P ET AL, "sn-1,2-Diacylglycerol kinase of Escherichia coli. Diacylglycerol analogs define specificity and mechanism", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (19900315), vol. 265, no. 8, ISSN 0021-9258, pages 4374 - 4381, XP002677411 [X] 1-8,10,14 * page 4375; table I; compound XXIV * | [X] - SAITO M ET AL, "SYNTHESIS AND INHIBITORY ACTIVITY OF ACYL-PEPTIDYL-PYRROLIDINE DERIVATIVES TOWARD POST-PROLINE CLEAVING ENZYME; A STUDY OF SUBSITE SPECIFICITY", JOURNAL OF ENZYME INHIBITION, NEW YORK, NY, US, (19910101), vol. 5, no. 1, pages 51 - 75, XP000197459 [X] 1-6,10,14 * page 54, lines 3-4; compounds 4-PhBuAlaOH * | [X] - LEVY B ET AL, "Phenylpropionyl-dl-alanine and Phenylbutyryldl-alanine", JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL SOCIETY, LETCHWORTH; GB, (19480101), vol. 71, ISSN 0368-1769, page 1512, XP002592291 [X] 1-6,10 * page 1512, column 1 * | [X] - INES MANDL ET AL, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (19500419), vol. 72, no. 4, doi:10.1021/ja01160a106, ISSN 0002-7863, pages 1790 - 1792, XP055043111 [X] 1-6,10 * entry 6; page 1790, column 2; table I * DOI: http://dx.doi.org/10.1021/ja01160a106 | [I] - MICHAL ENTIN-MEER ET AL, "AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines", CANCER LETTERS, (20070801), vol. 253, no. 2, doi:10.1016/j.canlet.2007.01.022, ISSN 0304-3835, pages 205 - 214, XP055043372 [I] 9,11,12,15 * page 206; table 1; compounds AN-113 * * page 206, column 1, lines 4-10 * DOI: http://dx.doi.org/10.1016/j.canlet.2007.01.022 | [A] - HAROLD L. NEWMARK ET AL, "Butyrate and phenylacetate as differentiating agents: Practical problems and opportunities", JOURNAL OF CELLULAR BIOCHEMISTRY, (19950101), vol. 59, no. S22, doi:10.1002/jcb.240590831, ISSN 0730-2312, pages 247 - 253, XP055043377 [A] 1-15 * abstract * DOI: http://dx.doi.org/10.1002/jcb.240590831 | by applicant | WO9300786 | WO9510271 | EP0725635 | EP1427396 | WO03022253 | - "Oral Drug Delivery", TAKADA, K.; YOSHIKAWA, H., Encyclopedia of Controlled Drug Delivery, JOHN WILEY & SONS, INC., (1999), vol. 2, pages 728 - 742 | - "Oral drug delivery, small intestine and colon", FIX, J., Encyclopedia of Controlled Drug Delivery, JOHN WILEY & SONS, INC., (1999), vol. 2, pages 698 - 728 |